-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-CD19CD20-ALLO1 in Primary Mediastinal B-Cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-CD19CD20-ALLO1 in Primary Mediastinal B-Cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-CD19CD20-ALLO1 in Primary Mediastinal B-Cell Lymphoma Drug Details: P-CD19CD20-ALL01...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – P-CD19CD20-ALLO1 in Marginal Zone B-cell Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - P-CD19CD20-ALLO1 in Marginal Zone B-cell Lymphoma report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. P-CD19CD20-ALLO1 in Marginal Zone B-cell Lymphoma Drug Details: P-CD19CD20-ALL01...
-
Sector Analysis
NewData Centers 2.0 – Transforming Tomorrow’s Compute
Data Centers 2.0 Report Overview As the digital landscape evolves, the role and design of data centers are undergoing a profound transformation. Central to this transformation is the integration of advanced network services virtualization, grid computing, and hybrid cloud management, alongside pioneering cooling systems and power management solutions. These advancements not only enhance the efficiency and scalability of data centers but also address the increasing environmental concerns associated with their energy consumption. The "Data Centers 2.0: Transforming Tomorrow's Compute" report...
-
Product Insights
Likelihood of Approval Analysis for Dementia Associated With Alzheimer’s Disease
Overview How likely is it that the drugs in Dementia Associated With Alzheimer's Disease will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dementia Associated With Alzheimer's Disease Overview Alzheimer's disease (AD)...
-
Product Insights
Likelihood of Approval Analysis for Dementia
Overview How likely is it that the drugs in Dementia will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dementia Overview Dementia is the decline in cognitive abilities that impacts a person's...
-
Product Insights
NewConstant Therapy Health Pipeline Insight and Competitive Landscape, 2023
Empower your strategies with our Constant Therapy Health Pipeline Insight and Competitive Landscape, 2023 report and make more profitable business decisions. Constant Therapy Health formerly The Learning Corp, a subsidiary of Digital Health Corp, is a digital therapeutics company that develops mobile therapy solutions. Its cognitive and speech therapy app, Constant Therapy, provides exercises pertaining to memory, speech, reading, and writing to support individuals recovering from stroke, traumatic brain injuries (TBI), learning disorders, and aphasia. The solution helps clinicians in...
-
Product Insights
Likelihood of Approval Analysis for Fibromyalgia (Fibromyalgia Syndrome)
Overview How likely is it that the drugs in Fibromyalgia (Fibromyalgia Syndrome) will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Fibromyalgia (Fibromyalgia Syndrome) Overview Fibromyalgia is a disorder characterized by widespread...
-
Thematic Analysis
NewHigh-Performance Computing – Thematic Intelligence
High-Performance Computing Thematic Intelligence Report Overview High-performance computing (HPC) is the use of supercomputers and parallel processing techniques to solve complex computational problems. HPC started as an array of independent monolithic systems and evolved into clusters that can run on hundreds of thousands of processors. The Internet of Things has created a data explosion. As the volume of IoT data increases, so does the amount of data that needs to be processed and stored, driving organizations globally to use high-performance...
-
Product Insights
Likelihood of Approval Analysis for Anesthetic Effect
Overview How likely is it that the drugs in Anesthetic Effect will get approved? Will the drugs transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LoA) and phase transition success rate (PTSR) of drugs using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Anesthetic Effect Overview Anesthesia or anaesthesia is a state of controlled, temporary...